Cardiovascular magnetic resonance imaging derived septal curvature in neonates with bronchopulmonary dysplasia associated pulmonary hypertension

Table 2 Cardiac MRI data for the study cohort

	N	No PH therapy	PH therapy in hospital	PH therapy at DC	P value
RVEDVi (ml/m2)	46	40.6 ± 10.7	37.7 ± 16.7	43.8 ± 8.5	0.56
RVESVi (ml/m2)	46	15.9 ± 5.0	15.0 ± 4.5	19.4 ± 6.5	0.17
RVEF (%)	46	60.6 ± 6.9	60.7 ± 6.2	56.6 ± 12.3	0.42
RV mass (g/m2)	46	13.1 ± 3.6	15.4 ± 5.7	16.7 ± 3.2	0.04
LVEDVi (ml/m2)	46	43.6 ± 9.7	43.1 ± 16.1	37.1 ± 7.7	0.26
LVESVi (ml/m2)	46	17.1 ± 6.0	16.4 ± 8.5	14.0 ± 3.1	0.41
LVEF (%)	46	61.4 ± 6.6	61.4 ± 5.7	62.9 ± 3.9	0.79
CI (L/min/m2)	46	4.3 ± 1.4	4.0 ± 1.4	3.7 ± 0.7	0.39
CMR-EI	48	1.09 ± 0.10	1.15 ± 0.15	1.32 ± 0.22	< 0.001
Septal Curvature	46	0.77 ± 0.18	0.60 ± 0.19	0.06 ± 0.3	< 0.001

Data are mean ± standard deviation
Abbreviations: RVEDVi RV end diastolic volume indexed to body surface area, RVESVi RV end systolic volume indexed to body surface area, RVEF RV ejection fraction, LVEDVi LV end diastolic volume indexed to body surface area, LVESVi LV end systolic volume indexed to body surface area, LVEF LV ejection fraction, CI cardiac index, CMR cardiovascular magnetic resonance, EI eccentricity index

ISSN: 1532-429X